Methods. Questionnaires and serum samples from a total of 2006 students who entered Edinburgh University in 1999-2000 were analyzed to examine risk factors for EBV seropositivity, both overall and by EBV type.
thereafter the virus establishes a latent infection of B lymphocytes that persists for life [1] . In nonindustrialized countries, almost all children over the age of 2 years are infected with EBV [2] , but, in areas of the world where standards of living are high, many escape childhood infection. These individuals are then susceptible to primary EBV infection later in life when IM may occur [3] , most commonly at ages 15-25 years in high socioeconomic groups [4] . Although usually selflimiting, IM may cause prolonged illness and fatigue and appears to be a risk factor for Hodgkin disease [5, 6] .
Although 2 childhood peaks of EBV seroconversion are known to occur-at ages 2-4 and 15 years [7, 8] only a few studies have attempted to identify the risk factors that are responsible. Indicators of high socioeconomic status have been found to be associated with increased likelihood of persistent EBV seronegativity into the teenage years [9] [10] [11] , but inconsistent results have been found for other risk factors. EBV is produced in the saliva of persistently infected individuals, and transmission almost certainly occurs orally through close salivary contact during kissing, but the virus has also been reported in both male and female genital secretions, suggesting that sexual transmission may occur [12] [13] [14] . In a recent seroepidemiological study of 11000 students entering Edinburgh University, sexual intercourse was identified as a significant risk factor for both EBV seropositivity and IM [15] .
Two distinct types of EBV (1 and 2, also called A and B) that show 70%-85% sequence homology were identified in the 1980s [16, 17] , but no epidemiological studies have been conducted examining whether they share risk factors. Several small studies suggest that type 1 EBV is more prevalent than type 2 and that type 2 is more common in Africa than elsewhere [18] . Most of these studies analyzed EBV types in tumor material or tumor-derived cell lines, and there have been few studies in healthy populations. One study found type 2 EBV to be more common in homosexual than heterosexual men [19] , and dual infection with types 1 and 2 has mainly been identified in conjunction with HIV infection [20] [21] [22] .
There is no specific treatment for IM, but a vaccine against EBV-specific gp350 aimed at preventing it is in clinical trials [23] . A vaccination strategy has yet to be formulated, however. This requires the identification of susceptible groups and risk factors for EBV seroconversion and IM.
We conducted a study of 12000 university entrants, collecting questionnaires and serum samples to identify sexual and nonsexual risk factors for EBV seroconversion overall and, for the first time, separately by EBV type.
SUBJECTS, MATERIALS, AND METHODS

Study population.
All students enrolling at the Edinburgh University Health Centre in October 1999 and October 2000 for courses lasting 4 or more years were invited to participate in the study. Those agreeing were asked to sign a consent form and complete a questionnaire that asked about demographic, behavioral, medical, and sexual characteristics before coming to the university. Participants were also asked to provide a blood sample to be tested for IgG antibodies in plasma and EBV type, by polymerase chain reaction (PCR) of peripheral-blood mononuclear cells (PBMCs). The study was approved by the Lothian Ethics Committee.
EBV serological analysis. Serum or plasma samples were initially tested for EBV-specific IgG antibodies to EB viral capsid antigen (VCA) by routine ELISA (Sigma). Negative results were checked by indirect immunofluorescence (IF) [24] . Equivocal serum samples were also tested for IgG antibodies to EB viral nuclear antigens (EBNA) by anticomplimentary IF [25] . Seronegativity was defined as VCA IgG negative (by ELISA and IF) and EBNA negative (where tested).
Type 1 and 2 detection. DNA was extracted from PBMCs by use of the Easy DNA Kit (Invitrogen) as per the manufacturer's instructions. The type of EBV (1 or 2) in each PBMC sample was determined by nested PCR amplification across a type-specific region of the EBNA 3C gene [26] .
Statistical methods. Statistical analyses were done to identify associations between possible risk factors and the seroprevalence of EBV antibodies overall and separately for type 1, type 2, and dual infections. Prevalence ratios (PRs) rather than odds ratios were used as a measure of the relative risk, because of the high level of EBV positivity among the students and, hence, violation of the rare-disease assumption [27] . A multivariate Poisson model with scale parameter adjusted by x 2 was used to obtain PRs and 95% confidence intervals (CIs) adjusted for confounding factors [28] . Analyses were conducted using the Stata statistical package (version 8.0; StataCorp) [29] .
RESULTS
Approximately 4000 students registered with the Edinburgh University Health Centre during 1999-2000, some three-quarters of whom were approached to take part in the study. The remainder were not approached because of the chaotic nature of the clinic during the registration procedure, which processed thousands of new students during the first few days of term. A total of 2006 students (63% female; average age, 18 years 8 months) were recruited into the study, of whom 1496 (75%) tested positive for EBV-specific IgG antibodies (table 1). Seropositivity was significantly higher ( ) among female P ! .001 (79%) than among male (68%) students, among those 19 years and older (80%) than among those younger (71%), and among those who had ever lived in a tropical country (81%) than among those who had not (73%). Analyses of the specific continents in which each student had lived showed little variation in seroprevalence across continents. Greater seroprevalence was found among students who were born in a tropical country than in those who had simply lived in one, with the greatest seroprevalence being among those born in Africa (94%), followed by South America (85%), other developing countries (83%), and Southeast Asia (79%).
Analyses of ethnicity were only possible for white versus nonwhite students, because of limited numbers in the latter group, and showed no evidence of a difference in seroprevalence. Seropositivity was significantly greater among students who had at least 1 sibling (75%) than among those with none (66%), although risk was not related to the number of siblings ( ), sex of the sibling, or the age(s) of the sibling(s) P p .40 trend relative to their proband.
There was no evidence that the average degree of crowding (number of rooms per person) in the students' home from birth to starting university was associated with EBV risk. Risk was also unrelated to the number of different vaccinations the student had ever received or to any particular allergy (asthma, eczema, hay fever, food, or other) or childhood infectious disease common in the United Kingdom (e.g., measles and chick- enpox). There was also no relation to risk for anthropological measurements (height and weight), behavioral factors (e.g., alcohol consumption and cigarette smoking), and schooling (number of schools attended and whether boarding).
A multivariate model that included the significant factors shown in table 1 (sex, age, siblings, and residence in a tropical country) showed a significant independent effect of each. Analyses separately for those students who had been sexually active before coming to the university and those who had not suggested that the effects of these significant factors were not modified by prior sexual behavior.
Sexual activity before coming to the university was significantly associated with increased risk of EBV seropositivity ( ), and risk increased significantly ( ) with the P ! .001 P ! .001 number of sex partners (table 2) . There was no evidence that these increased risks were influenced by other sexual or nonsexual factors (e.g., smoking and oral contraceptive use). Risk was lower among students who reported always using a condom than among those who reported intercourse without one ( ), a result that was borderline significant ( ) P p .02 P p .05 after adjustment for number of sex partners. There was no clear evidence that risk depended on the sex of the partner, although seroprevalence was nonsignificantly lower among homosexual students than among other sexually active students. We were unable to examine the effect of oral genital sex because we did not specifically ask about this in the questionnaire.
Analysis of the factors in table 2 separately for males and females produced no decisive evidence that their effects were sex dependent, although the protective effect of condom use was apparent only in males ( ), and the difference in effect P ! .05 between males and females for this variable was borderline significant ( ). EBV seroprevalence was significantly (P P p .06 ! .001) lower among current oral contraceptive users (60%) than among sexually active nonusers (91%), a result that remained significant after adjustment for other factors (e.g., number of sex partners, condom use, and age).
Of the 1496 EBV-positive serum samples from students, successful typing of EBV type 1, type 2, or dual infection was accomplished for 617 (41%); the remaining 879 were tested, but typing was not successful. There was no age difference between those successfully typed and those not successfully typed, but there was some suggestion ( ) that typing was P p .05 more successful among females (43%) than among males (38%). Among those successfully typed, type 1 infection was detected in 78% of students, type 2 in 17%, and dual infection in 5%.
As with EBV seropositivity overall, the prevalence of type 1 infection was significantly ( ) greater among female P ! .001 (48%) than among male (33%) students and among students with siblings (44%) than among those without (28%) (P ! ), even after adjustment for sexual activity (table 3) . Type 1 .05 infection was also greater among older students and those who had lived in a tropical country, although both of these results were borderline significant after adjustment for sexual activity. As with EBV risk overall, these significant findings were not modified by prior sexual behavior.
In contrast, based on smaller numbers, type 2 risk was similar in males and females and was reduced, although not significantly so, among students with siblings (table 3) . Dual-infection risks broadly mirrored those for type 1 infection but were generally less significant because of the smaller numbers.
The effect of sexual behavior on the risks of type 1, type 2, and dual infection are shown in table 4. The risk of type 1 infection was significantly ( ) increased among students P ! .001 who had been sexually active prior to coming to the university, with the risk increasing with the number of sex partners ( ), and was lower among those who had homo-P p .006 trend sexual compared with other sexual relationships. The latter result remained significant after adjustment for number of sex partners. The protective effect of condom use on type 1 infection was not significant. Analyses of type 1 risks separately for males and females showed that the increase in risk with the number of sex partners was more consistent in females ( ) than males ( ). The lower risk of type P p .02 P p .08 trend trend 1 infection among homosexual students than among other sexually active students was apparent, although not significant, for both sexes. The protective effect of condom use on type 1 infection was apparent among males (PR, 0.83) but not materially among females (PR, 0.96), although neither of the 2 PRs, or the difference between them, was significant. As with EBV risk overall, current oral contraceptive use was significantly protective ( ) against type 1 infection, even after adjust-P ! .01 ment for other sexual and nonsexual factors.
Although associated with sexual activity, the risk of type 2 infection did not appear to be lower among homosexual students than among other sexually active students or to increase consistently with the number of sex partners. The lower risk of type 2 infection among those who always used a condom than among those who had sexual intercourse without one was not significant. Sex-specific analyses of these factors for type 2 infection were inconclusive because of small numbers.
The PRs of dual infection associated with sexual activity were broadly similar to those for type 1 infection but, being based on much smaller numbers, there was no apparent reduction in risk among homosexual students than among heterosexual or bisexual students or among condom users. Sex-specific analyses of dual infection were difficult to interpret because of small numbers.
DISCUSSION
Risk factors for primary EBV infection have not been fully investigated, and the present study was undertaken in a large student population to elucidate these and to identify risk factors separately for EBV types 1 and 2. Among university entrants agreeing to participate, 75% were seropositive for EBV-specific IgG antibodies. Approximately 30% of students who were asked to participate declined to do so. This nonparticipation rate is reasonably low for a study involving venepuncture and recruitment from a noninstitutionalized, healthy population. It is unlikely that nonparticipation could have been directly related to EBV status, because students were unaware of their EBV status at the time of recruitment. It is possible, however, that nonparticipation may have been associated with factors that are themselves associated with EBV risk-for example, personality and, hence, sexual behavior-and so our estimate of 75% seroprevalence should be treated with some caution. Similar studies conducted 30 years ago in university entrants and US army recruits [30] [31] [32] found 45%-69% to be EBV seropositive, so the present study provides some evidence that childhood and early adolescent infections may have increased over time. Morris and Edmunds [33] reported a decrease in general practitioner consultations for IM from 1970 to 1999 in England and Wales, particularly among young children, but it was apparent in young adults as well. Curiously, Morris and Edmunds also observed a dramatic increase in hospitalizations due to IM during the 1990s, so the patterns of change in EBV transmission are unclear. Investigation of large historical serum banks might elucidate trends in EBV seroprevalence over time.
Few studies have attempted to identify risk factors for childhood seroconversion. Only age and indicators of low socioeconomic status have been unequivocally identified [9] [10] [11] .
We found an increased seroprevalence among females that appeared to be confined to type 1 infection. This might indicate greater childhood susceptibility to type 1 virus among females or could be a consequence of adolescent sexual behavior: increased risk might occur among females because, on average, they form relationships with men older than themselves who are thus more likely to be EBV (in this case, type 1) positive.
We were unable to adjust our results for the age of sex partner, but we could take account of whether the student had ever been sexually active; this did not change the results, suggesting that childhood, rather than sexual, factors are the reason for increased seropositivity among females. Previous studies have found conflicting evidence regarding sex differences in EBV prevalence, though none, to our knowledge, have examined type 1 and type 2 separately. Two childhood studies in Africa [34, 35] found little difference in EBV seroprevalence between boys and girls but found that high titers (11:160) were more common in girls. European studies [10, 36] have generally found no difference in EBV seroprevalence between males and females at any age, although one study [37] found higher seroprevalence among teenage girls than among teenage boys.
The seroprevalence of EBV infection among residents of temperate countries who had previously lived in the tropics has not been examined before. The finding of increased seroprevalence among such students accords with the much greater seropositivity among children in tropical than in nontropical countries [2] . It is noteworthy, however, that, among our students, type 1 as well as type 2 risk was increased, despite type 2 infections being more prevalent in Africa [18] . We found the greatest seroprevalence among students who were born in a tropical country, suggesting that risks are greatest among those who are resident in tropical countries early in life. One potential explanation could be that transmission can occur during child birth from young mothers shedding virus in their cervix.
The greater risk of EBV type 1 infection in students with siblings than in those without is likely due to transmission of type 1 virus from an infected brother or sister, although we found no evidence that the risk increased with the number of siblings or with having older siblings. Previous smaller studies of the association between the presence of siblings and EBV seroconversion have not distinguished between type 1 and type 2 and have produced conflicting results: several found no association [9, 11, 36] , whereas one found increased seroprevalence among subjects with siblings [38] . The confinement of our results to type 1 infection suggests a greater susceptibility to sibling transmission of this type. Prospective studies that examine the serological status of all siblings within a family, from infancy through the teenage years, could elucidate the transmission patterns of the virus within a family setting.
As demonstrated in an earlier study of part of this cohort [15] , sexual activity is a strong risk factor for EBV positivity, with the risk increasing with the number of sex partners. The present analyses suggest that this is particularly so for type 1 infection. These data suggest the possibility that EBV may be transmitted by sexual intercourse, and, given that the virus has been demonstrated in both male and female genital secretions [12] [13] [14] , this is certainly a possibility. However, these findings alone cannot distinguish between transmission of virus directly in genital fluids and transmission of salivary virus by kissing during sexual intercourse, particularly since a greater number of sex partners accords with a greater number of oral contacts. We therefore asked sexually active participants about condom use and found a lower seroprevalence among those who always used condoms than among sexually active nonusers or irregular users, suggesting that infection could be acquired by the sexual route. However, this difference could be due to differences in other kinds of sexual activity (e.g., oral contact might be more intrusive with more risky sexual behavior), particularly because the seroprevalence among those who always used condoms remained greater than that among sexually inactive students. Alternatively, students reporting that they always used condom may have been overstating the truth, diluting the protective effect in our results. The protective effect of condom use was apparent, although not significant, for both type 1 and type 2 infection. Sex-specific analyses suggested that the protection might apply only to males, but this could reflect sex differences in the reliability of reporting of condom use.
Our unexpected finding of a lower seroprevalence among females who were currently taking oral contraceptives than among sexually active nonusers remained significant after adjustment for other factors. Therefore, this could indicate hormonal involvement in susceptibility to EBV transmission.
The distribution of EBV types found in the present study (type, 1 77%; type 2, 17%; and dual infection, 5%) was similar to that found in smaller studies in Europe and the United States. Given that most infections are with type 1 EBV, it is unsurprising that type 1 risk factors were similar to those for EBV overall. Type 1 infection prevalence appeared to be greater in heterosexual and bisexual study participants but, in contrast to the findings of a previous study [19] , there was no evidence that type 2 infection was more common among homosexual than heterosexual men. The suggestion that dual infection is restricted to people who are immunocompromised-particularly those with HIV infection [20] [21] [22] -could not be examined directly in our study, because ethics approval was not granted for HIV testing. However, 5% of the subjects in our study had dual infection, and it is unlikely that 5% of the study participants had HIV infection or another major immunocompromised condition; thus, other risk factors are probably involved in dual infection, which need investigation in a larger study.
Several methodological issues need to be considered in the interpretation of the present findings. This was a retrospective cross-sectional study, and the quality of information on risk factors was, therefore, dependent on the accuracy of the recall of events that took place years earlier. This could produce bias if the accuracy of recall was different between EBV-positive and -negative subjects, but, given that the students were unaware of their serological status, only nondifferential misclassification seems likely. This would lead to the underestimation of risks and the potentially failure to detect true associations but should not lead to the detection of false-positive findings [39] . The main outcome measures in the present study, EBV serological status and EBV type, were determined using validated laboratory methods and, therefore, are unlikely to be inaccurate. We were unable to type virus for 59% of the EBV-positive serum samples that were collected in the study. The factors that determine successful typing are unknown but might relate to EBV load. We found some evidence that typing was more successful among female than among male students, but there is no obvious reason why overrepresentation of females in the typespecific analyses would distort the risk-factor findings we have reported.
In conclusion, the present study provides further evidence that EBV may be sexually transmitted and new evidence that the risk factors for type 1 and type 2 EBV infection may differ. In light of findings that IM is caused significantly more often by EBV type 1 than type 2 infection [40] , along with in vitro evidence of the different biological properties of the 2 types [41] , it seems increasingly likely that infection by these types has different predisposing factors.
